Contact Information
Company Information
Company
TILT Biotherapeutics Ltd
Technologies
Outlook
Microsoft Office 365
YouTube
Apache
Mobile Friendly
Typekit
AI
Keywords
oncolytic viruses
solid tumors
cancer
immunotherapy
oncoimmunology
tcell therapy
immune checkpoint inhibitors
biotechnology research
oncolytic immunotherapy
tilt-123
cancer treatment
t-cell stimulation
cytokine therapy
adenoviral vector
tumor microenvironment
checkpoint inhibitors
car t therapy
immuno-oncology
phase 1 clinical trials
clinical pipeline
biotechnology
tumor-infiltrating lymphocytes
intravascular administration
immune response enhancement
cancer vaccines
antitumor efficacy
biologics
cancer immunotherapy
clinical research
cancer therapeutics
il-2
tnf alpha
chimeric adenovirus
safety profile
combination therapies
systemic delivery
preclinical models
cancer cell selectivity
biomedical innovation
scientific publications
research & development
university collaboration
european innovation council
business finland
patent portfolio
market potential
targeted cancer therapy
molecular profiling
immune system modulation
therapeutic strategies
intratumoral injection
investor relations
business development
clinical advancements
future of immunotherapy
b2b
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans